Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • Our new issue of Px Wire offers an advocate’s guide to some new types of biomedical prevention trial designs. You’ll find a handy summary of long-acting PrEP trials, a lexicon of key terms for the "post-placebo era", and a handy illustration for looking smart while you explain "double-dummy double-blind".

    May 11, 2017
    Antibody Related Research, PrEP
  • Join us in our month-long “deep dive” into the dynamic field of HIV vaccine research with the next installment in our HIV Vaccine Awareness Day webinar series coming up this Thursday. And read on for links to key resources, including quick references and recordings of our other webinars.

    May 2, 2017
    Antibody Related Research, HIV Vaccine
  • In this webinar, we were joined by Dr. James Kiarie, coordinator of the Human Reproduction Team at the World Health Organization. Dr. Kiarie presented new guidance from WHO on hormonal contraceptive eligibility for women at high risk of HIV.

    April 26, 2017
  • Rob Newells, Executive Director for the AIDS Project of the East Bay, reports back on what caught his attention at the Conference on Retroviruses and Opportunistic Infections and his experience as one of very few African America attendees.

    April 24, 2017
    Antibody Related Research, Cure, PrEP
    Rob Newells
  • In April, countries across Africa review and finalize their annual PEPFAR-supported HIV programs. AVAC joined Health Gap and MSMGF to support and prepare MSM advocates attending the reviews.

    April 20, 2017
  • In this piece, Udom Likhitwonnawut, a long-time advocate for community engagement in HIV research in Thailand, argues in favor of PrEP in Thailand.

    April 20, 2017
    Udom Likhitwonnawut
  • Julie Patterson, an HIV prevention research advocate, discusses her experience earlier this year at the Conference on Retroviruses and Opportunistic Infections (CROI). Initially encouraged by programming geared toward advocate, she came away disappointed, wondering if researchers were listening.

    April 20, 2017
    Antibody Related Research, General
    Julie Patterson
  • This year will mark the 20th anniversary of HIV Vaccine Awareness Day (HVAD). On this May 18, as HIV prevention advocates we find ourselves in new terrain when it comes to vaccine research—both in terms of scientific progress and the challenging political environment. And read on for a range of HVAD tools and resources for the day and for year-round vaccine advocacy.

    April 20, 2017
  • How many doses of oral PrEP must be taken to build up protective levels of drug in the blood? In a webinar, representatives from the CDC and WHO will review their respective guidance development processes and the role, use, contexts and audience for guidance documents. Recording now available.

    April 4, 2017
  • AMP. Licensure. Enrollment targets. Success. These were the buzz words from the HIV Vaccine Trials Network regional meeting last month, highlighting the HVTN’s build out of programs in sub-Saharan Africa and the significance of an HIV vaccine for this region.

    March 21, 2017
    Ruth Assefa
    Stacey Hannah